EurekaMag.com logo
+ Site Statistics
References:
54,215,046
Abstracts:
30,230,908
PMIDs:
28,215,208
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The effect of the angiotensin II receptor antagonist CV-11974 on cerebral blood flow autoregulation



The effect of the angiotensin II receptor antagonist CV-11974 on cerebral blood flow autoregulation



Acta Neurologica Scandinavica 89(SUPPL 155): 11




(PDF emailed within 1 workday: $29.90)

Accession: 033785350

Download citation: RISBibTeXText



Related references

Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation. Journal of Hypertension 13(7): 755-761, 1995

The angiotensin AT1 receptor antagonist CV-11974 regulates cerebral blood flow and brain angiotensin AT1 receptor expression. Basic Research in Cardiology 93(SUPPL 2): 63-68, 1998

No effect of angiotensin II AT(2)-receptor antagonist PD 123319 on cerebral blood flow autoregulation. Journal of the Renin-Angiotensin-Aldosterone System 2(3): 188-192, 2002

Prolonged treatment with the AT1 antagonist CV-11974 shifts the cerebral blood flow autoregulation towards lower pressures in hypertensive and normotensive rats. FASEB Journal 12(4): A111, March 17, 1998

Effect of angiotensin II antagonist infusion on autoregulation of renal blood flow. American Journal of Physiology 231(4): 1267-1271, 1976

Effect of an angiotensin II receptor antagonist, CV-11974, and its prodrug, TCV-116, on production of aldosterone. European Journal of Pharmacology 253(1-2): 27-34, 1994

Inhibitory effect of an angiotensin II receptor antagonist, CV-11974, and its prodrug TCV-116, on production of aldosterone. Japanese Journal of Pharmacology 64(SUPPL 1): 334P, 1994

Effect of an AT1 receptor antagonist (CV-11974) on angiotensin II-induced cardiomyocyte hypertrophy in vitro. Blood Pressure. Supplement 5: 84-88, 1994

Protective effect of angiotensin II type I receptor antagonist, CV-11974, on ischemia and reperfusion injury of the liver. Transplantation (Baltimore) 71(8): 1034-1039, April 27, 2001

Nonpeptide angiotensin AT-1 and AT-2 receptor ligands modulate the upper limit of cerebral blood flow autoregulation in rats. Journal Of Cerebral Blood Flow & Metabolism. 13(2): 298-303, 1993

Angiotensin II AT-2 receptor stimulation extends the upper limit of cerebral blood flow autoregulation: Agonist effects of CGP 42112 and PD 123319. Journal of Cerebral Blood Flow and Metabolism 14(1): 38-44, 1994

CV-11974 A nonpeptide angiotensin II type 1 receptor antagonist. Cardiovascular Drug Reviews 15(1): 59-74, 1997

Angiotensin converting enzyme inhibition and the upper limit of cerebral blood flow autoregulation: effect of sympathetic stimulation. Circulation Research 64(6): 1197-1204, 1989

Preservation of cerebral blood flow autoregulation under angiotensin-converting enzyme inhibition and angiotensin II antagonism in experimental hypertension. European Journal of Clinical Investigation 25(SUPPL 2): A20, 1995

Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonist. Biochemical Pharmacology 46(2): 311-318, 1993